AAAAAA
Results:
1-10
|
Results: 10
Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vegote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, INT J GYN C, 11, 2001, pp. 20-20
Authors:
Onsrud, M
Strickert, T
Marthinsen, ABL
Citation: M. Onsrud et al., Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: A comparison of standardized and individualized target volumes, INT J RAD O, 49(3), 2001, pp. 749-755
Authors:
Onsrud, M
Hagen, B
Strickert, T
Citation: M. Onsrud et al., 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri, GYNECOL ONC, 82(1), 2001, pp. 167-171
Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vergote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, ANN ONCOL, 11(3), 2000, pp. 281-288
Authors:
Hagen, B
Skjeldestad, FE
Halvorsen, T
Strickert, T
Tingulstad, S
Lorenz, E
Onsrud, M
Citation: B. Hagen et al., Primary treatment of cervical carcinoma - Ten years experience from one Norwegian health region, ACT OBST SC, 79(12), 2000, pp. 1093-1099
Authors:
Lorenz, E
Hagen, B
Himmelmann, A
Kjorstadt, K
Onsrud, M
Tingulstad, S
Gundersen, G
Citation: E. Lorenz et al., A phase II study of biweekly administration of paclitaxel in patients withrecurrent epithelial ovarian cancer, INT J GYN C, 9(5), 1999, pp. 373-376
Authors:
Hagen, B
Onsrud, M
Dale, O
Citation: B. Hagen et al., A pharmacokinetic and clinical evaluation of thio-TEPA in combination withcisplatin as first-line chemotherapy for advanced epithelial ovarian carcinoma, INT J GYN C, 9(2), 1999, pp. 110-116
Authors:
Sert, MB
Onsrud, M
Perrone, T
Abbas, F
Currie, JL
Citation: Mb. Sert et al., Malignant rhabdoid tumor of the vulva. Case report, EUR J GYN O, 20(4), 1999, pp. 258-261
Authors:
Tingulstad, S
Hagen, B
Skjeldestad, FE
Halvorsen, T
Nustad, K
Onsrud, M
Citation: S. Tingulstad et al., The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals, OBSTET GYN, 93(3), 1999, pp. 448-452
Authors:
Trope, C
Hogberg, T
Kaern, J
Bertelsen, K
Bjorkholm, E
Boman, K
Himmelmann, A
Horvath, G
Jacobsen, A
Kuoppola, T
Vartianen, J
Lund, B
Onsrud, M
Puistola, U
Salmi, T
Scheistroen, M
Sandvei, R
Simonsen, E
Sorbe, B
Tholander, B
Westberg, R
Citation: C. Trope et al., Long-term results from a phase II study of single agent paclitaxel (Taxol (R)) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience, ANN ONCOL, 9(12), 1998, pp. 1301-1307
Risultati:
1-10
|